• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Clinical characteristics of the patients with asymptomatic primary hyperparathyroidism.无症状原发性甲状旁腺功能亢进症患者的临床特征。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2021 Apr 28;46(4):368-372. doi: 10.11817/j.issn.1672-7347.2021.200356.
2
Clinical Characteristics of Primary Hyperparathyroidism: 15-Year Experience of 457 Patients in a Single Center in China.原发性甲状旁腺功能亢进症的临床特征:中国单中心 15 年 457 例患者的经验。
Front Endocrinol (Lausanne). 2021 Feb 25;12:602221. doi: 10.3389/fendo.2021.602221. eCollection 2021.
3
Characteristics, management, and outcome of primary hyperparathyroidism at a single clinical center from 2005 to 2016.2005 年至 2016 年单一临床中心原发性甲状旁腺功能亢进症的特征、治疗及预后。
Osteoporos Int. 2018 Mar;29(3):635-642. doi: 10.1007/s00198-017-4322-7. Epub 2017 Dec 3.
4
New parathyroid function index for the differentiation of primary and secondary hyperparathyroidism: a case-control study.新甲状旁腺功能指数在原发性和继发性甲状旁腺功能亢进症鉴别诊断中的应用:一项病例对照研究。
BMC Endocr Disord. 2020 Jan 8;20(1):5. doi: 10.1186/s12902-019-0487-8.
5
Progressive rise in the prevalence of asymptomatic primary hyperparathyroidism in India: Data from PHPT registry.印度无症状原发性甲状旁腺功能亢进症患病率的逐渐上升:PHPT 登记处的数据。
J Bone Miner Metab. 2021 Mar;39(2):253-259. doi: 10.1007/s00774-020-01142-w. Epub 2020 Sep 7.
6
Parathyroidectomy for adults with primary hyperparathyroidism.甲状旁腺切除术治疗原发性甲状旁腺功能亢进症成人患者。
Cochrane Database Syst Rev. 2023 Mar 8;3(3):CD013035. doi: 10.1002/14651858.CD013035.pub2.
7
The characteristics of clinical changes in primary hyperparathyroidism in Chinese patients.原发性甲状旁腺功能亢进症中国患者的临床变化特征。
J Bone Miner Metab. 2019 Mar;37(2):336-341. doi: 10.1007/s00774-018-0922-3. Epub 2018 May 2.
8
Simultaneous expression analysis of vitamin D receptor, calcium-sensing receptor, cyclin D1, and PTH in symptomatic primary hyperparathyroidism in Asian Indians.在有症状的原发性甲状旁腺功能亢进症的亚洲印第安人中同时表达维生素 D 受体、钙敏感受体、细胞周期蛋白 D1 和 PTH。
Eur J Endocrinol. 2013 Jun 7;169(1):109-16. doi: 10.1530/EJE-13-0085. Print 2013 Jul.
9
Primary Hyperparathyroidism.原发性甲状旁腺功能亢进症。
Front Horm Res. 2019;51:1-12. doi: 10.1159/000491034. Epub 2018 Nov 19.
10
Clinical, Biochemical, and Radiological Profile of Normocalcemic Primary Hyperparathyroidism.血钙正常型原发性甲状旁腺功能亢进的临床、生化和影像学特征。
J Clin Endocrinol Metab. 2020 Jul 1;105(7). doi: 10.1210/clinem/dgaa174.

引用本文的文献

1
Symptomatic versus asymptomatic primary hyperparathyroidism: A systematic review and meta-analysis.症状性与无症状性原发性甲状旁腺功能亢进症:一项系统评价和荟萃分析。
J Clin Transl Endocrinol. 2023 Mar 31;32:100317. doi: 10.1016/j.jcte.2023.100317. eCollection 2023 Jun.

本文引用的文献

1
The characteristics of clinical changes in primary hyperparathyroidism in Chinese patients.原发性甲状旁腺功能亢进症中国患者的临床变化特征。
J Bone Miner Metab. 2019 Mar;37(2):336-341. doi: 10.1007/s00774-018-0922-3. Epub 2018 May 2.
2
Characteristics, management, and outcome of primary hyperparathyroidism at a single clinical center from 2005 to 2016.2005 年至 2016 年单一临床中心原发性甲状旁腺功能亢进症的特征、治疗及预后。
Osteoporos Int. 2018 Mar;29(3):635-642. doi: 10.1007/s00198-017-4322-7. Epub 2017 Dec 3.
3
Primary hyperparathyroidism: insights from the Indian PHPT registry.原发性甲状旁腺功能亢进症:来自印度原发性甲状旁腺功能亢进症登记处的见解。
J Bone Miner Metab. 2018 Mar;36(2):238-245. doi: 10.1007/s00774-017-0833-8. Epub 2017 Mar 31.
4
Prevalence and Determinants of Suboptimal Vitamin D Levels in a Multiethnic Asian Population.多民族亚洲人群中维生素D水平未达最佳状态的患病率及其决定因素
Nutrients. 2017 Mar 22;9(3):313. doi: 10.3390/nu9030313.
5
The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism.美国内分泌外科学会原发性甲状旁腺功能亢进症确定性治疗指南。
JAMA Surg. 2016 Oct 1;151(10):959-968. doi: 10.1001/jamasurg.2016.2310.
6
Preoperative diagnosis and prognosis in 40 Parathyroid Carcinoma Patients.40例甲状旁腺癌患者的术前诊断与预后
Clin Endocrinol (Oxf). 2016 Jul;85(1):29-36. doi: 10.1111/cen.13055. Epub 2016 Mar 31.
7
Parathyroid: The Pathology of Hyperparathyroidism.甲状旁腺:甲状旁腺功能亢进的病理学
Surg Pathol Clin. 2014 Dec;7(4):515-31. doi: 10.1016/j.path.2014.08.004. Epub 2014 Oct 6.
8
Parathyroid Carcinoma: Diagnosis and Clinical Implications.甲状旁腺癌:诊断及临床意义
Turk Patoloji Derg. 2015;31 Suppl 1:80-97. doi: 10.5146/tjpath.2015.01316.
9
ASYMPTOMATIC PRIMARY HYPERPARATHYROIDISM EXISTS IN NORTH INDIA: RETROSPECTIVE DATA FROM 2 TERTIARY CARE CENTERS.无症状原发性甲状旁腺功能亢进症在印度北部存在:来自两家三级医疗中心的回顾性数据。
Endocr Pract. 2015 Jun;21(6):581-5. doi: 10.4158/EP14447.OR. Epub 2015 Feb 9.
10
Bone disease in primary hyperparathyroidism.原发性甲状旁腺功能亢进症中的骨病
Arq Bras Endocrinol Metabol. 2014 Jul;58(5):553-61. doi: 10.1590/0004-2730000003381.

无症状原发性甲状旁腺功能亢进症患者的临床特征。

Clinical characteristics of the patients with asymptomatic primary hyperparathyroidism.

机构信息

Department of Endocrinology, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038.

Department of Otolaryngology Head and Neck Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038.

出版信息

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2021 Apr 28;46(4):368-372. doi: 10.11817/j.issn.1672-7347.2021.200356.

DOI:10.11817/j.issn.1672-7347.2021.200356
PMID:33967082
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10930305/
Abstract

OBJECTIVES

The prevalence of asymptomatic primary hyperparathyroidism (PHPT) in China is lower than that in European and American countries and the study about the characteristics of asymptomatic PHPT was rare in China. This study aims to explore the characteristics of asymptomatic PHPT.

METHODS

Clinical data of 150 patients with PHPT confirmed by operation and pathological examination were retrospectively analyzed. The patients were assigned into a symptomatic PHPT group (=124) and an asymptomatic PHPT group (=26).

RESULTS

The proportion of adenomas was higher than that of adenocarcinoma in the asymptomatic PHPT group. The proportion of the first diagnosis due to hypercalcemia found via biochemical examination in the asymptomatic PHPT group was higher than that in the symptomatic PHPT group (76.92% vs 25.81%, <0.001). The duration was shorter in the asymptomatic PHPT patients than that in the symptomatic PHPT patients (median 12 months vs 24 months, =0.004). The serum calcium, the albumin-corrected serum calcium, and parathyroid hormone (PTH) were lower in the asymptomatic PHPT patients than those in the symptomatic PHPT (=0.003, =0.006, and =0.042, respectively). The serum 1,25-dihydroxyvitamin D was higher (<0.001), the diameter was shorter (=0.028), and the bone mineral densities (BMD) of L and femoral neck were higher in the asymptomatic PHPT patients than those in the symptomatic PHPT patients (both <0.001).

CONCLUSIONS

Only a minority of PHPT patients are asymptomatic. Compared with the symptomatic PHPT patients, the primary cause of diagnosis is hypercalcemia, the duration of diagnosis and the diameter of parathyroid gland are shorter, the levels of serum calcium, and PTH are lower, the proportion of adenomas, vitamin D, and the BMD of L and femoral neck are higher, and the pathological type is benign in the asymptomatic PHPT patients.

摘要

目的

中国无症状原发性甲状旁腺功能亢进症(PHPT)的患病率低于欧美国家,且国内对无症状 PHPT 特征的研究较少。本研究旨在探讨无症状 PHPT 的特征。

方法

回顾性分析 150 例经手术和病理检查证实的 PHPT 患者的临床资料,将患者分为有症状 PHPT 组(n=124)和无症状 PHPT 组(n=26)。

结果

无症状 PHPT 组中腺瘤的比例高于腺癌。无症状 PHPT 组中因生化检查发现高钙血症而首次诊断的比例高于有症状 PHPT 组(76.92%比 25.81%,<0.001)。无症状 PHPT 患者的病程短于有症状 PHPT 患者(中位数 12 个月比 24 个月,=0.004)。无症状 PHPT 患者的血清钙、白蛋白校正血清钙和甲状旁腺激素(PTH)水平低于有症状 PHPT 患者(均<0.001)。血清 1,25-二羟维生素 D 水平较高(<0.001),直径较短(=0.028),L 和股骨颈的骨密度(BMD)较高(均<0.001)。

结论

仅有少数 PHPT 患者无症状。与有症状 PHPT 患者相比,无症状 PHPT 患者的主要诊断原因是高钙血症,诊断病程和甲状旁腺直径较短,血清钙和 PTH 水平较低,腺瘤、维生素 D 和 L 及股骨颈 BMD 的比例较高,且病理类型为良性。